Cite
Singh AK, Bhadauria AS, Kumar U, et al. Author Correction: Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals. Sci Rep. 2020;10(1):2391doi: 10.1038/s41598-020-59134-9.
Singh, A. K., Bhadauria, A. S., Kumar, U., Raj, V., Rai, A., Kumar, P., Keshari, A. K., Kumar, D., Maity, B., Nath, S., Prakash, A., & Saha, S. (2020). Author Correction: Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals. Scientific reports, 10(1), 2391. https://doi.org/10.1038/s41598-020-59134-9
Singh, Ashok K, et al. "Author Correction: Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals." Scientific reports vol. 10,1 (2020): 2391. doi: https://doi.org/10.1038/s41598-020-59134-9
Singh AK, Bhadauria AS, Kumar U, Raj V, Rai A, Kumar P, Keshari AK, Kumar D, Maity B, Nath S, Prakash A, Saha S. Author Correction: Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals. Sci Rep. 2020 Feb 06;10(1):2391. doi: 10.1038/s41598-020-59134-9. PMID: 32024920; PMCID: PMC7002741.
Copy
Download .nbib